Clinical trial · Observational
Clinical and Laboratory Characteristics of Polycythemia Vera
NCT06134102CI-TRIAL-00078913PV-ARCcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is observational, longitudinal, retrospective and prospective, on patients with PV. Patients with PV diagnosed from 2000 to 2023 according to WHO2017 criteria will be considered. The main purpose of the study is to determine the impact of clinical and laboratory characteristics of Polycythemia Vera on patients' prognosis, understood as long-term survival
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycythemia Vera | Polycythemia Vera | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Long-term survival
- timeFrame
- 6 years
- description
- To determine the impact of clinical and laboratory characteristics of Polycythemia Vera (PV) on patients' prognosis, in terms of lon term survival
Secondary outcomes (7)
- measure
- Thrombosis
- timeFrame
- 6 years
- description
- To assess the incidence of thrombotic events on PV patients
- measure
- Haemorrhages
- timeFrame
- 6 years
- description
- To assess the incidence of haemorrhagic events on PV patients
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with PV according to WHO 2017 criteria, * Obtaining informed consent for data collection and processing Exclusion Criteria: * None
References
Publications (1)
- DERIVEDPalandri F, Dedola A, Caocci G, Rossi E, Elli EM, Sartor C, Latagliata R, Pugliese N, Morsia E, Binotto G, Mendicino F, Tieghi A, Benevolo G, Martino B, D'Addio A, Tiribelli M, Cilloni D, Crugnola M, Cavalca F, Scalzulli E, Lanza F, Pane F, Palumbo GA, Heidel FH, De Stefano V, Breccia M, Branzanti F. A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib. Blood Adv. 2026 Aug 11;10(15):5469-5479. doi: 10.1182/bloodadvances.2026020255. PMID 42275537